3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Marijuana Abuse
3
Pain
2
Neoplasms
2
Glioblastoma
2
Signs and Symptoms
1
Recurrence
1
Parasomnias
1
Pancreatic Neoplasms
1
Nausea
1
Marijuana Use
1
Cancer Pain
1
Cachexia
1
Brain Neoplasms
1
Anxiety Disorders
1
Anorexia
1
Advanced Malignant Solid Tumor
1
1- Cancer Patients During Chemotherapy Treatment
1
Interventions
Granulocyte-Macrophage Colony-Stimulating Factor
2
Colony-Stimulating Factors
2
nabiximols
1
fludarabine
1
camrelizumab
1
Radiofrequency Ablation
1
Interleukin-2
1
Immune Checkpoint Inhibitors
1
Cyclophosphamide
1
Adjuvants, Immunologic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Malignant Solid Tumor
×
nabiximols
×
Clear all
NCT07459920
2026-03-10
CAPTURE
National Cancer Institute, Naples
Phase 2
Not yet recruiting
156 enrolled